InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Tucker John H, Chairman & CEO. Director active across 1 company, notably scPharmaceuticals Inc.. Aggregated, 8 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €35k. Activity tracked since 3 December 2021. The latest transaction was disclosed on 11 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
122,345 sharesCommon StockSEC:0001193125-25-233532:0
200,000 shares0Common StockSEC:0000950170-25-018923:0
13,360 shares@ US$3.55878.8% of flowCommon StockSEC:0000950170-25-002872:0
113,560 shares0Common StockSEC:0000950170-24-006214:0
4,942 shares@ US$6.395.5% of flowCommon StockSEC:0000950170-24-000976:0
66,665 shares@ US$6.1472.3% of flowCommon StockSEC:0000899243-23-002427:0
42,250 sharesCommon StockSEC:0000899243-22-033404:0
10,000 shares@ US$3.955350.0% of flowCommon StockSEC:0000899243-21-046979:0
Ideal exit: 30 Aug 2022 (T+270)
8 of 8 declarations
About Tucker John H
John H. Tucker serves as President and Chief Executive Officer of scPharmaceuticals Inc. As CEO, he leads the company and is responsible for overall strategy and operations. His expertise in the pharmaceutical sector is essential for driving innovation and growth at scPharmaceuticals.
